Comparison of Visual Acuity Performed in Office Versus In Residence
NCT ID: NCT05250986
Last Updated: 2022-02-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
325 participants
OBSERVATIONAL
2022-02-14
2022-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparing a Home Vision Self-Assessment Test to Office-Based Snellen Visual Acuity in Myopic Children
NCT06529367
Prospective Evaluation of a Smartphone Application, GoCheckKids™, to Detect Amblyopia Risk Factors in Young Children
NCT03447171
Evaluation of a Smartphone Application, GoCheckKids™ as a Photo Screening Tool in a Pediatric Population
NCT03119675
Study to Evaluate the Reliability, Validity and Safety of Subjective Mobile Refraction
NCT05049070
Comparing Vision Tests in a Virtual Reality Headset to Existing Analogues
NCT04714424
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The test methodology utilizes modified ETDRS design features with HOTV or Sloan optotypes (based on age), crowding bars, and displays 3 optotypes at a time (arranged vertically) to accommodate smaller screen sizes, but still significantly shortens testing time as opposed to displaying only a single optotype at a time.
The application may be used to screen children old enough to comprehend the test, typically around age 4 through adulthood, during their primary care, or school-based visits, and now, in the home. The purpose of home vision testing is to provide actionable insights into the status of an individual's vision without the need for an in-office visit. The testing results will be able to used by the physician to help determine if additional interventions are necessary.
The objective of this study is to determine if the results of the GoCheck visual acuity test performed in an office setting correlate to the same testing when implemented in the residence.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
GoCheck Kids (iOS)
Visual Acuity method is used to measure of the sharpness or clearness of vision.
Device: GoCheck Visual Acuity in Office (Windows) Photorefraction method is used to screen amblyopia risk factors.
GoCheck Kids (Windows)
Visual Acuity method is used to measure of the sharpness or clearness of vision.
GoCheck at Home (iOS)
Visual Acuity method is used to measure of the sharpness or clearness of vision.
GoCheck at Home (Windows)
Visual Acuity method is used to measure of the sharpness or clearness of vision.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Corrected visual acuity range of 20/16 to 20/100
3. Manifest or cycloplegic refraction within prior six (6) months
4. Ability to comprehend and complete the VA test with age appropriate optotypes
Exclusion Criteria
2. Inability to read, write, and/or understand English
3. Inability to provide written informed consent or have consent conferred on patient's behalf
4. Subjects from populations otherwise deemed ineligible/unable to provide informed consent and/or participate in studies (detention, correction, rehabilitation, psychiatric residents, etc.)
5. Current pregnancy
6. Any ocular pathology defect(s) except amblyopia, strabismus or refractive error or history of nystagmus.
4 Years
20 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gobiquity Mobile Health
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David Huang, MD
Role: STUDY_CHAIR
Oregon Health and Science University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alaska Children's Eye & Strabismus
Anchorage, Alaska, United States
Yale School of Medicine, Yale University
New Haven, Connecticut, United States
Medical University of South Carolina-Storm Eye Institute
Charleston, South Carolina, United States
Stern Hospital
Haifa, Tel Aviv, Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Robert Arnold, MD
Role: primary
Jill Rotruck, MD
Role: primary
Mae Peterseim, MD
Role: primary
Tamara Wygnanski-Jaffe, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.